Hypofractionated Radiotherapy for Prostate Cancer: Further Evidence to Tip the Scales

Affiliations

Editorial

James B Yu. J Clin Oncol. 2017.

. 2017 Jun 10;35(17):1867-1869.

doi: 10.1200/JCO.2017.72.7016. Epub 2017 Mar 29.

No abstract available

Comment on

Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer.
Catton CN, Lukka H, Gu CS, Martin JM, Supiot S, Chung PWM, Bauman GS, Bahary JP, Ahmed S, Cheung P, Tai KH, Wu JS, Parliament MB, Tsakiridis T, Corbett TB, Tang C, Dayes IS, Warde P, Craig TK, Julian JA, Levine MN. Catton CN, et al. J Clin Oncol. 2017 Jun 10;35(17):1884-1890. doi: 10.1200/JCO.2016.71.7397. Epub 2017 Mar 15. J Clin Oncol. 2017. PMID: 28296582 Clinical Trial.
Moderate Hypofractionation in High-Risk, Organ-Confined Prostate Cancer: Final Results of a Phase III Randomized Trial.
Arcangeli G, Saracino B, Arcangeli S, Gomellini S, Petrongari MG, Sanguineti G, Strigari L. Arcangeli G, et al. J Clin Oncol. 2017 Jun 10;35(17):1891-1897. doi: 10.1200/JCO.2016.70.4189. Epub 2017 Mar 29. J Clin Oncol. 2017. PMID: 28355113 Clinical Trial.